PepTech Corporation - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

PepTech Corporation

Description:

Need to streamline drug development process. Mounting R&D costs per drug: 1 bn per drug ... Greater acceptance of and confidence in outsourced work ... – PowerPoint PPT presentation

Number of Views:41
Avg rating:3.0/5.0
Slides: 21
Provided by: lifescienc6
Category:

less

Transcript and Presenter's Notes

Title: PepTech Corporation


1
PepTech Corporation
The Current Trends of Chinas CRO Industry
Bruno Tse, Ph.D., M.B.A. VP, Business
Development PepTech Corporation
2
PepTech Corporation
  • PepTech Corp Basic Facts
  • Pharma CRO Industry
  • Outsourcing to China Current Trends
  • What to look for in a Chinese CRO

3
Drug Development Process
PepTech
4
PepTech CorporationBasic Facts
  • 15-year track record of providing top chemistry
    services and products to the pharmaceutical
    industry
  • gt800 Customers worldwide
  • HQ in Massachusetts 2 plants in Shanghai (RD
    center Metric-ton Manufacturing Plant)

5
PepTech CorporationBasic Facts
  • Organic Growth Independent
  • Problem-Solving and Broad Chemistry Expertise

Chiral Building Blocks (e.g. amino acids)
Heteroaromatic Chemistry (e.g. boronic acids)
Medicinal Chemistry Compounds Libraries
Process RD and Manufacturing (up to MT)
6
Pharma RD SpendingOn the Rise
CAGR 8.7

65.2 bn
CAGR 8.5
Source PhRMA Oppenheimer Co. and www.eatg.org
7
Need for Outsourcing
  • In need of faster, more cost-effective RD
  • Patent Expiration (65 bn revenue void in four
    years)
  • Pipelines to fill
  • -- Need to streamline drug development process
  • Mounting RD costs per drug gt1 bn per drug
  • -- Need to cut costs
  • Complexity of the drug development process
  • -- Vast fields of expertise and knowledge
  • required from research to regulatory


8
Pharma OutsourcingOn the Rise
14 growth
Pharma insights marketresearch.com
9
Outsourcing on the Rise
How much do you expect your RD outsourcing
spending to grow in the next year?
Why do you outsource RD spending?
Focus on core competencies 42
None 17
gt10 more 21
Temporary lack of capacity 29
Less 7
1-5 more 17
Company is virtual 21
6-10 more38
Lifecycle Management 8
Source Contract Pharma Outsourcing Survey, May
2008
10
CRO Market
11
CRO Market 14 growth
  • Shift toward Outsourcing Continues
  • Pharma RD spending gt 60 bn 8.5 growth
  • Main reasons for outsourcing
  • Focus on core competencies
  • Reduce cost and RD time
  • CROs can save up to 9-11 months to reach IND
  • Can save pre-IND costs by up to 55
  • Access to specific expertise new
    technologies
  • Lack of Capacity
  • Virtual Company
  • Greater acceptance of and confidence in
    outsourced work
  • Current CRO market at 19bn (preclinical 4.4
    bn)
  • 14 annual growth

12
Reasons for Outsourcing to China
  • Why outsource to China?
  • Lower costs
  • Lower cost of living
  • FTE in China approx. 1/3 that of US
  • Highly skilled labor
  • Large supply of scientists and lab technicians
  • 5 times as many graduates in chemistry at B.S.
    level
  • 3 times as many graduates in chemistry
    at graduate level
  • (China population 1.3 bn US population 300
    MM)
  • Strengthening of IP laws (WTO 2002)

13
Main Reason for Lower CostsLower Labor Costs
All three categories are degree holders with at
least 1 year of related experiences and recruited
locally China Salary mainly refers to
Zhangjiang, Shanghai where many Chinese CRO
companies locate Compensation expenses include
salaries and salaries related expenses likes
taxes and various contributions the employers
have to pay. Source BNP Paribas estimates
14
Outsourcing to China Other Facts
  • Pharma outsourcing market in china
  • 3.4 bn USD (2006) 7.2 bn USD (2011)
  • Large patient pool easier to find and recruit
    patients
  • Patient enrollment time in China ½ that in
    US
  • Rich animal resources
  • China supplies 80 of primates used in
    preclinical testing
  • 1,000/monkey in China versus 10,000-20,000/monk
    ey in US

15
Outsourcing to China Other Facts
  • Chinese government invests 600 MM per year in
    RD
  • ln 2006, launched a 15-year plan to become
    one of the top
  • countries for innovations in science and
    technology.
  • Many multinational pharma companies have
    established
  • presence in China, particularly in Shanghai
    Zhangjiang
  • Attractive consumer opportunity for pharma
    products
  • Pharmaceutical consumer market 20 annual
    growth
  • Expected to be the ninth largest by 2009
    with 20 bn sales annually

16
Chinese CRO Industry
  • Crowded field with a few dominant players
  • Key factors for a company to sustain in long
    term
  • HIGH QUALITY (ideally with lower cost)
  • Differentiated products/services
  • Timely deliveries
  • Communication with clients
  • Track record
  • Broad service portfolio

17
What to look for in a Chinese CRO?
Track Record History References Quality
Communications (Advantage with US-based HQ)
Evaluate your needs, e.g. Short-term versus
long-term (start with smaller projects,
audits) Info handling

Timely Deliveries, Competitive Pricing
Security (Procedures to handle sensitive informati
on)
18
PepTech Corporation
The most influential import from China in recent
years is ___________________
19
PepTech Corporation
YAO MING !!!
20
PepTech Corporation
Thank You !
Write a Comment
User Comments (0)
About PowerShow.com